| 摘要 |
This invention relates to compounds of the nature: N-[4-(aminoiminomethyl)benzoyl]-4-oxyacetic acid-(R)-prolylbenzene; N-[4-(aminoiminomethyl)benzoyl]-4-oxyacetic acid-(R)- psi -(R,S)-hydroxymethyl-prolylbenzene; (R)-[4-{(1-[4-(aminoiminomethyl)benzoyl]-2-pyrrolidinyl)carbonyl}-2-(2-phenylethyl)phenoxy]acetic acid; (R)-[4-{(1-[4-(aminocarbonyl)benzoyl]-2-pyrrolidinyl)carbonyl}-2-(2-phenylethyl)phenoxy]acetic acid; (R)-[4-{(1-[4-(aminomethyl)benzoyl]-2-pyrrolidinyl)carbonyl}-phenoxy]acetic acid; ethyl (R)-[4-{(1-[4-(aminoiminomethyl)benzoyl]-2-pyrrolidinyl)carbonyl}-phenoxy]acetate; or a pharmaceutically acceptable salt thereof, which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such an activity, and a method for inhibiting platelet aggregation. |
